nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—CYP3A4—Methylprednisolone—psoriatic arthritis	0.071	0.248	CbGbCtD
Lurasidone—CYP3A4—Triamcinolone—psoriatic arthritis	0.0538	0.188	CbGbCtD
Lurasidone—CYP3A4—Betamethasone—psoriatic arthritis	0.0462	0.161	CbGbCtD
Lurasidone—CYP3A4—Prednisolone—psoriatic arthritis	0.0456	0.159	CbGbCtD
Lurasidone—CYP3A4—Prednisone—psoriatic arthritis	0.043	0.15	CbGbCtD
Lurasidone—CYP3A4—Dexamethasone—psoriatic arthritis	0.0269	0.0938	CbGbCtD
Lurasidone—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.00221	0.0031	CcSEcCtD
Lurasidone—Lethargy—Methotrexate—psoriatic arthritis	0.0022	0.00308	CcSEcCtD
Lurasidone—Cerebrovascular accident—Methotrexate—psoriatic arthritis	0.0022	0.00308	CcSEcCtD
Lurasidone—Arrhythmia—Prednisolone—psoriatic arthritis	0.00219	0.00307	CcSEcCtD
Lurasidone—Osteoarthritis—Methotrexate—psoriatic arthritis	0.00215	0.00302	CcSEcCtD
Lurasidone—Eye disorder—Methylprednisolone—psoriatic arthritis	0.0021	0.00295	CcSEcCtD
Lurasidone—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00209	0.00293	CcSEcCtD
Lurasidone—Bradycardia—Dexamethasone—psoriatic arthritis	0.00208	0.00292	CcSEcCtD
Lurasidone—Bradycardia—Betamethasone—psoriatic arthritis	0.00208	0.00292	CcSEcCtD
Lurasidone—Neutropenia—Prednisone—psoriatic arthritis	0.00208	0.00292	CcSEcCtD
Lurasidone—Erectile dysfunction—Prednisone—psoriatic arthritis	0.00205	0.00287	CcSEcCtD
Lurasidone—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00204	0.00286	CcSEcCtD
Lurasidone—Weight increased—Prednisone—psoriatic arthritis	0.00203	0.00284	CcSEcCtD
Lurasidone—Arrhythmia—Triamcinolone—psoriatic arthritis	0.00201	0.00282	CcSEcCtD
Lurasidone—Vision blurred—Prednisolone—psoriatic arthritis	0.00201	0.00282	CcSEcCtD
Lurasidone—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.00201	0.00282	CcSEcCtD
Lurasidone—Hyperglycaemia—Prednisone—psoriatic arthritis	0.00201	0.00282	CcSEcCtD
Lurasidone—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00197	0.00276	CcSEcCtD
Lurasidone—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00196	0.00275	CcSEcCtD
Lurasidone—Angioedema—Prednisolone—psoriatic arthritis	0.00195	0.00273	CcSEcCtD
Lurasidone—Breast disorder—Methotrexate—psoriatic arthritis	0.00195	0.00273	CcSEcCtD
Lurasidone—Malaise—Prednisolone—psoriatic arthritis	0.00193	0.0027	CcSEcCtD
Lurasidone—Vertigo—Prednisolone—psoriatic arthritis	0.00192	0.00269	CcSEcCtD
Lurasidone—Syncope—Prednisolone—psoriatic arthritis	0.00191	0.00268	CcSEcCtD
Lurasidone—Eye disorder—Dexamethasone—psoriatic arthritis	0.00191	0.00268	CcSEcCtD
Lurasidone—Eye disorder—Betamethasone—psoriatic arthritis	0.00191	0.00268	CcSEcCtD
Lurasidone—Back pain—Triamcinolone—psoriatic arthritis	0.0019	0.00266	CcSEcCtD
Lurasidone—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00188	0.00263	CcSEcCtD
Lurasidone—Angiopathy—Betamethasone—psoriatic arthritis	0.00186	0.0026	CcSEcCtD
Lurasidone—Angiopathy—Dexamethasone—psoriatic arthritis	0.00186	0.0026	CcSEcCtD
Lurasidone—Convulsion—Prednisolone—psoriatic arthritis	0.00185	0.00259	CcSEcCtD
Lurasidone—Hypertension—Prednisolone—psoriatic arthritis	0.00184	0.00258	CcSEcCtD
Lurasidone—Eosinophilia—Methotrexate—psoriatic arthritis	0.00184	0.00258	CcSEcCtD
Lurasidone—Arrhythmia—Dexamethasone—psoriatic arthritis	0.00183	0.00256	CcSEcCtD
Lurasidone—Arrhythmia—Betamethasone—psoriatic arthritis	0.00183	0.00256	CcSEcCtD
Lurasidone—Bradycardia—Prednisone—psoriatic arthritis	0.00181	0.00254	CcSEcCtD
Lurasidone—Angioedema—Triamcinolone—psoriatic arthritis	0.00179	0.00251	CcSEcCtD
Lurasidone—Angioedema—Methylprednisolone—psoriatic arthritis	0.00179	0.00251	CcSEcCtD
Lurasidone—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00178	0.0025	CcSEcCtD
Lurasidone—Malaise—Triamcinolone—psoriatic arthritis	0.00177	0.00248	CcSEcCtD
Lurasidone—Malaise—Methylprednisolone—psoriatic arthritis	0.00177	0.00248	CcSEcCtD
Lurasidone—Vertigo—Triamcinolone—psoriatic arthritis	0.00176	0.00247	CcSEcCtD
Lurasidone—Syncope—Triamcinolone—psoriatic arthritis	0.00176	0.00247	CcSEcCtD
Lurasidone—Vertigo—Methylprednisolone—psoriatic arthritis	0.00176	0.00247	CcSEcCtD
Lurasidone—Syncope—Methylprednisolone—psoriatic arthritis	0.00176	0.00246	CcSEcCtD
Lurasidone—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00175	0.00245	CcSEcCtD
Lurasidone—Dysuria—Methotrexate—psoriatic arthritis	0.00174	0.00244	CcSEcCtD
Lurasidone—Neutropenia—Methotrexate—psoriatic arthritis	0.00174	0.00244	CcSEcCtD
Lurasidone—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00173	0.00242	CcSEcCtD
Lurasidone—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00172	0.00241	CcSEcCtD
Lurasidone—Shock—Prednisolone—psoriatic arthritis	0.00171	0.0024	CcSEcCtD
Lurasidone—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.00171	0.0024	CcSEcCtD
Lurasidone—Convulsion—Triamcinolone—psoriatic arthritis	0.0017	0.00238	CcSEcCtD
Lurasidone—Tachycardia—Prednisolone—psoriatic arthritis	0.0017	0.00238	CcSEcCtD
Lurasidone—Convulsion—Methylprednisolone—psoriatic arthritis	0.0017	0.00238	CcSEcCtD
Lurasidone—Hypertension—Triamcinolone—psoriatic arthritis	0.0017	0.00238	CcSEcCtD
Lurasidone—Hypertension—Methylprednisolone—psoriatic arthritis	0.00169	0.00237	CcSEcCtD
Lurasidone—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00168	0.00236	CcSEcCtD
Lurasidone—Myalgia—Triamcinolone—psoriatic arthritis	0.00167	0.00234	CcSEcCtD
Lurasidone—Myalgia—Methylprednisolone—psoriatic arthritis	0.00167	0.00234	CcSEcCtD
Lurasidone—Eye disorder—Prednisone—psoriatic arthritis	0.00167	0.00233	CcSEcCtD
Lurasidone—Anxiety—Methylprednisolone—psoriatic arthritis	0.00166	0.00233	CcSEcCtD
Lurasidone—Infestation NOS—Methotrexate—psoriatic arthritis	0.00166	0.00233	CcSEcCtD
Lurasidone—Infestation—Methotrexate—psoriatic arthritis	0.00166	0.00233	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00166	0.00232	CcSEcCtD
Lurasidone—Dry mouth—Triamcinolone—psoriatic arthritis	0.00163	0.00229	CcSEcCtD
Lurasidone—Renal failure—Methotrexate—psoriatic arthritis	0.00163	0.00229	CcSEcCtD
Lurasidone—Angioedema—Dexamethasone—psoriatic arthritis	0.00163	0.00228	CcSEcCtD
Lurasidone—Angioedema—Betamethasone—psoriatic arthritis	0.00163	0.00228	CcSEcCtD
Lurasidone—Angiopathy—Prednisone—psoriatic arthritis	0.00162	0.00227	CcSEcCtD
Lurasidone—Malaise—Dexamethasone—psoriatic arthritis	0.00161	0.00225	CcSEcCtD
Lurasidone—Malaise—Betamethasone—psoriatic arthritis	0.00161	0.00225	CcSEcCtD
Lurasidone—Vertigo—Betamethasone—psoriatic arthritis	0.0016	0.00224	CcSEcCtD
Lurasidone—Vertigo—Dexamethasone—psoriatic arthritis	0.0016	0.00224	CcSEcCtD
Lurasidone—Syncope—Dexamethasone—psoriatic arthritis	0.0016	0.00224	CcSEcCtD
Lurasidone—Syncope—Betamethasone—psoriatic arthritis	0.0016	0.00224	CcSEcCtD
Lurasidone—Arrhythmia—Prednisone—psoriatic arthritis	0.00159	0.00223	CcSEcCtD
Lurasidone—Infection—Triamcinolone—psoriatic arthritis	0.00159	0.00223	CcSEcCtD
Lurasidone—Infection—Methylprednisolone—psoriatic arthritis	0.00159	0.00223	CcSEcCtD
Lurasidone—Shock—Triamcinolone—psoriatic arthritis	0.00158	0.00221	CcSEcCtD
Lurasidone—Insomnia—Prednisolone—psoriatic arthritis	0.00158	0.00221	CcSEcCtD
Lurasidone—Shock—Methylprednisolone—psoriatic arthritis	0.00157	0.0022	CcSEcCtD
Lurasidone—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00157	0.0022	CcSEcCtD
Lurasidone—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00157	0.0022	CcSEcCtD
Lurasidone—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00157	0.00219	CcSEcCtD
Lurasidone—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00157	0.00219	CcSEcCtD
Lurasidone—Tachycardia—Triamcinolone—psoriatic arthritis	0.00156	0.00219	CcSEcCtD
Lurasidone—Mental disorder—Prednisone—psoriatic arthritis	0.00156	0.00219	CcSEcCtD
Lurasidone—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00156	0.00219	CcSEcCtD
Lurasidone—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00155	0.00218	CcSEcCtD
Lurasidone—Malnutrition—Prednisone—psoriatic arthritis	0.00155	0.00217	CcSEcCtD
Lurasidone—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00155	0.00217	CcSEcCtD
Lurasidone—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00155	0.00217	CcSEcCtD
Lurasidone—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00155	0.00217	CcSEcCtD
Lurasidone—Convulsion—Dexamethasone—psoriatic arthritis	0.00154	0.00216	CcSEcCtD
Lurasidone—Convulsion—Betamethasone—psoriatic arthritis	0.00154	0.00216	CcSEcCtD
Lurasidone—Hypertension—Betamethasone—psoriatic arthritis	0.00154	0.00216	CcSEcCtD
Lurasidone—Hypertension—Dexamethasone—psoriatic arthritis	0.00154	0.00216	CcSEcCtD
Lurasidone—Myalgia—Dexamethasone—psoriatic arthritis	0.00152	0.00213	CcSEcCtD
Lurasidone—Myalgia—Betamethasone—psoriatic arthritis	0.00152	0.00213	CcSEcCtD
Lurasidone—Anxiety—Dexamethasone—psoriatic arthritis	0.00151	0.00212	CcSEcCtD
Lurasidone—Anxiety—Betamethasone—psoriatic arthritis	0.00151	0.00212	CcSEcCtD
Lurasidone—Hypotension—Methylprednisolone—psoriatic arthritis	0.00149	0.00209	CcSEcCtD
Lurasidone—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00147	0.00206	CcSEcCtD
Lurasidone—Vision blurred—Prednisone—psoriatic arthritis	0.00146	0.00205	CcSEcCtD
Lurasidone—Urethral disorder—Methotrexate—psoriatic arthritis	0.00146	0.00205	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00146	0.00205	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00146	0.00204	CcSEcCtD
Lurasidone—Insomnia—Triamcinolone—psoriatic arthritis	0.00145	0.00203	CcSEcCtD
Lurasidone—Insomnia—Methylprednisolone—psoriatic arthritis	0.00145	0.00203	CcSEcCtD
Lurasidone—Infection—Betamethasone—psoriatic arthritis	0.00144	0.00202	CcSEcCtD
Lurasidone—Infection—Dexamethasone—psoriatic arthritis	0.00144	0.00202	CcSEcCtD
Lurasidone—Anaemia—Prednisone—psoriatic arthritis	0.00143	0.00201	CcSEcCtD
Lurasidone—Shock—Dexamethasone—psoriatic arthritis	0.00143	0.002	CcSEcCtD
Lurasidone—Shock—Betamethasone—psoriatic arthritis	0.00143	0.002	CcSEcCtD
Lurasidone—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00143	0.002	CcSEcCtD
Lurasidone—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00143	0.002	CcSEcCtD
Lurasidone—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00143	0.002	CcSEcCtD
Lurasidone—Agitation—Prednisone—psoriatic arthritis	0.00143	0.002	CcSEcCtD
Lurasidone—Tachycardia—Dexamethasone—psoriatic arthritis	0.00142	0.00199	CcSEcCtD
Lurasidone—Tachycardia—Betamethasone—psoriatic arthritis	0.00142	0.00199	CcSEcCtD
Lurasidone—Angioedema—Prednisone—psoriatic arthritis	0.00142	0.00199	CcSEcCtD
Lurasidone—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00141	0.00198	CcSEcCtD
Lurasidone—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00141	0.00197	CcSEcCtD
Lurasidone—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00141	0.00197	CcSEcCtD
Lurasidone—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00141	0.00197	CcSEcCtD
Lurasidone—Malaise—Prednisone—psoriatic arthritis	0.0014	0.00196	CcSEcCtD
Lurasidone—Vertigo—Prednisone—psoriatic arthritis	0.00139	0.00195	CcSEcCtD
Lurasidone—Eye disorder—Methotrexate—psoriatic arthritis	0.00139	0.00195	CcSEcCtD
Lurasidone—Syncope—Prednisone—psoriatic arthritis	0.00139	0.00195	CcSEcCtD
Lurasidone—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00138	0.00194	CcSEcCtD
Lurasidone—Fatigue—Triamcinolone—psoriatic arthritis	0.00138	0.00194	CcSEcCtD
Lurasidone—Fatigue—Methylprednisolone—psoriatic arthritis	0.00138	0.00193	CcSEcCtD
Lurasidone—Loss of consciousness—Prednisone—psoriatic arthritis	0.00136	0.00191	CcSEcCtD
Lurasidone—Hypotension—Betamethasone—psoriatic arthritis	0.00136	0.0019	CcSEcCtD
Lurasidone—Hypotension—Dexamethasone—psoriatic arthritis	0.00136	0.0019	CcSEcCtD
Lurasidone—Angiopathy—Methotrexate—psoriatic arthritis	0.00135	0.00189	CcSEcCtD
Lurasidone—Convulsion—Prednisone—psoriatic arthritis	0.00134	0.00188	CcSEcCtD
Lurasidone—Hypertension—Prednisone—psoriatic arthritis	0.00134	0.00188	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00132	0.00186	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00132	0.00186	CcSEcCtD
Lurasidone—Myalgia—Prednisone—psoriatic arthritis	0.00132	0.00185	CcSEcCtD
Lurasidone—Anxiety—Prednisone—psoriatic arthritis	0.00132	0.00184	CcSEcCtD
Lurasidone—Insomnia—Betamethasone—psoriatic arthritis	0.00132	0.00184	CcSEcCtD
Lurasidone—Insomnia—Dexamethasone—psoriatic arthritis	0.00132	0.00184	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00131	0.00184	CcSEcCtD
Lurasidone—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00131	0.00183	CcSEcCtD
Lurasidone—Mental disorder—Methotrexate—psoriatic arthritis	0.0013	0.00183	CcSEcCtD
Lurasidone—Malnutrition—Methotrexate—psoriatic arthritis	0.0013	0.00182	CcSEcCtD
Lurasidone—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00128	0.00179	CcSEcCtD
Lurasidone—Dyspepsia—Betamethasone—psoriatic arthritis	0.00128	0.00179	CcSEcCtD
Lurasidone—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00126	0.00177	CcSEcCtD
Lurasidone—Decreased appetite—Betamethasone—psoriatic arthritis	0.00126	0.00177	CcSEcCtD
Lurasidone—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00126	0.00177	CcSEcCtD
Lurasidone—Infection—Prednisone—psoriatic arthritis	0.00126	0.00176	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00126	0.00176	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00126	0.00176	CcSEcCtD
Lurasidone—Back pain—Methotrexate—psoriatic arthritis	0.00125	0.00176	CcSEcCtD
Lurasidone—Fatigue—Betamethasone—psoriatic arthritis	0.00125	0.00176	CcSEcCtD
Lurasidone—Fatigue—Dexamethasone—psoriatic arthritis	0.00125	0.00176	CcSEcCtD
Lurasidone—Shock—Prednisone—psoriatic arthritis	0.00125	0.00175	CcSEcCtD
Lurasidone—Nervous system disorder—Prednisone—psoriatic arthritis	0.00124	0.00174	CcSEcCtD
Lurasidone—Tachycardia—Prednisone—psoriatic arthritis	0.00124	0.00173	CcSEcCtD
Lurasidone—Skin disorder—Prednisone—psoriatic arthritis	0.00123	0.00172	CcSEcCtD
Lurasidone—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00122	0.00172	CcSEcCtD
Lurasidone—Vision blurred—Methotrexate—psoriatic arthritis	0.00122	0.00171	CcSEcCtD
Lurasidone—Anaemia—Methotrexate—psoriatic arthritis	0.0012	0.00168	CcSEcCtD
Lurasidone—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00119	0.00167	CcSEcCtD
Lurasidone—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00119	0.00167	CcSEcCtD
Lurasidone—Malaise—Methotrexate—psoriatic arthritis	0.00117	0.00164	CcSEcCtD
Lurasidone—Vertigo—Methotrexate—psoriatic arthritis	0.00116	0.00163	CcSEcCtD
Lurasidone—Leukopenia—Methotrexate—psoriatic arthritis	0.00116	0.00163	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00115	0.00162	CcSEcCtD
Lurasidone—Dizziness—Prednisolone—psoriatic arthritis	0.00115	0.00162	CcSEcCtD
Lurasidone—Asthenia—Triamcinolone—psoriatic arthritis	0.00115	0.00161	CcSEcCtD
Lurasidone—Abdominal pain—Betamethasone—psoriatic arthritis	0.00115	0.00161	CcSEcCtD
Lurasidone—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00115	0.00161	CcSEcCtD
Lurasidone—Asthenia—Methylprednisolone—psoriatic arthritis	0.00115	0.00161	CcSEcCtD
Lurasidone—Insomnia—Prednisone—psoriatic arthritis	0.00115	0.00161	CcSEcCtD
Lurasidone—Pruritus—Triamcinolone—psoriatic arthritis	0.00113	0.00159	CcSEcCtD
Lurasidone—Pruritus—Methylprednisolone—psoriatic arthritis	0.00113	0.00159	CcSEcCtD
Lurasidone—Convulsion—Methotrexate—psoriatic arthritis	0.00112	0.00157	CcSEcCtD
Lurasidone—Dyspepsia—Prednisone—psoriatic arthritis	0.00111	0.00156	CcSEcCtD
Lurasidone—Myalgia—Methotrexate—psoriatic arthritis	0.0011	0.00155	CcSEcCtD
Lurasidone—Decreased appetite—Prednisone—psoriatic arthritis	0.0011	0.00154	CcSEcCtD
Lurasidone—Rash—Prednisolone—psoriatic arthritis	0.0011	0.00154	CcSEcCtD
Lurasidone—Dermatitis—Prednisolone—psoriatic arthritis	0.0011	0.00154	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.0011	0.00154	CcSEcCtD
Lurasidone—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00109	0.00153	CcSEcCtD
Lurasidone—Fatigue—Prednisone—psoriatic arthritis	0.00109	0.00153	CcSEcCtD
Lurasidone—Dizziness—Triamcinolone—psoriatic arthritis	0.00106	0.00149	CcSEcCtD
Lurasidone—Dizziness—Methylprednisolone—psoriatic arthritis	0.00106	0.00148	CcSEcCtD
Lurasidone—Infection—Methotrexate—psoriatic arthritis	0.00105	0.00147	CcSEcCtD
Lurasidone—Asthenia—Betamethasone—psoriatic arthritis	0.00104	0.00146	CcSEcCtD
Lurasidone—Asthenia—Dexamethasone—psoriatic arthritis	0.00104	0.00146	CcSEcCtD
Lurasidone—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00104	0.00145	CcSEcCtD
Lurasidone—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00104	0.00145	CcSEcCtD
Lurasidone—Nausea—Prednisolone—psoriatic arthritis	0.00103	0.00145	CcSEcCtD
Lurasidone—Pruritus—Dexamethasone—psoriatic arthritis	0.00103	0.00144	CcSEcCtD
Lurasidone—Pruritus—Betamethasone—psoriatic arthritis	0.00103	0.00144	CcSEcCtD
Lurasidone—Skin disorder—Methotrexate—psoriatic arthritis	0.00103	0.00144	CcSEcCtD
Lurasidone—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00102	0.00143	CcSEcCtD
Lurasidone—Vomiting—Triamcinolone—psoriatic arthritis	0.00102	0.00143	CcSEcCtD
Lurasidone—Vomiting—Methylprednisolone—psoriatic arthritis	0.00102	0.00142	CcSEcCtD
Lurasidone—Rash—Triamcinolone—psoriatic arthritis	0.00101	0.00142	CcSEcCtD
Lurasidone—Dermatitis—Triamcinolone—psoriatic arthritis	0.00101	0.00141	CcSEcCtD
Lurasidone—Rash—Methylprednisolone—psoriatic arthritis	0.00101	0.00141	CcSEcCtD
Lurasidone—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00101	0.00141	CcSEcCtD
Lurasidone—Abdominal pain—Prednisone—psoriatic arthritis	0.001	0.0014	CcSEcCtD
Lurasidone—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000995	0.00139	CcSEcCtD
Lurasidone—Diarrhoea—Betamethasone—psoriatic arthritis	0.000995	0.00139	CcSEcCtD
Lurasidone—Hypotension—Methotrexate—psoriatic arthritis	0.000989	0.00139	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000964	0.00135	CcSEcCtD
Lurasidone—Dizziness—Dexamethasone—psoriatic arthritis	0.000961	0.00135	CcSEcCtD
Lurasidone—Dizziness—Betamethasone—psoriatic arthritis	0.000961	0.00135	CcSEcCtD
Lurasidone—Insomnia—Methotrexate—psoriatic arthritis	0.000957	0.00134	CcSEcCtD
Lurasidone—Nausea—Triamcinolone—psoriatic arthritis	0.000952	0.00133	CcSEcCtD
Lurasidone—Nausea—Methylprednisolone—psoriatic arthritis	0.00095	0.00133	CcSEcCtD
Lurasidone—Dyspnoea—Methotrexate—psoriatic arthritis	0.000943	0.00132	CcSEcCtD
Lurasidone—Somnolence—Methotrexate—psoriatic arthritis	0.000941	0.00132	CcSEcCtD
Lurasidone—Dyspepsia—Methotrexate—psoriatic arthritis	0.000931	0.00131	CcSEcCtD
Lurasidone—Vomiting—Dexamethasone—psoriatic arthritis	0.000924	0.0013	CcSEcCtD
Lurasidone—Vomiting—Betamethasone—psoriatic arthritis	0.000924	0.0013	CcSEcCtD
Lurasidone—Decreased appetite—Methotrexate—psoriatic arthritis	0.00092	0.00129	CcSEcCtD
Lurasidone—Rash—Betamethasone—psoriatic arthritis	0.000917	0.00128	CcSEcCtD
Lurasidone—Rash—Dexamethasone—psoriatic arthritis	0.000917	0.00128	CcSEcCtD
Lurasidone—Dermatitis—Betamethasone—psoriatic arthritis	0.000916	0.00128	CcSEcCtD
Lurasidone—Dermatitis—Dexamethasone—psoriatic arthritis	0.000916	0.00128	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000914	0.00128	CcSEcCtD
Lurasidone—Fatigue—Methotrexate—psoriatic arthritis	0.000912	0.00128	CcSEcCtD
Lurasidone—Asthenia—Prednisone—psoriatic arthritis	0.000908	0.00127	CcSEcCtD
Lurasidone—Pruritus—Prednisone—psoriatic arthritis	0.000896	0.00126	CcSEcCtD
Lurasidone—Diarrhoea—Prednisone—psoriatic arthritis	0.000866	0.00121	CcSEcCtD
Lurasidone—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000865	0.00121	CcSEcCtD
Lurasidone—Nausea—Betamethasone—psoriatic arthritis	0.000864	0.00121	CcSEcCtD
Lurasidone—Nausea—Dexamethasone—psoriatic arthritis	0.000864	0.00121	CcSEcCtD
Lurasidone—Dizziness—Prednisone—psoriatic arthritis	0.000837	0.00117	CcSEcCtD
Lurasidone—Abdominal pain—Methotrexate—psoriatic arthritis	0.000837	0.00117	CcSEcCtD
Lurasidone—Vomiting—Prednisone—psoriatic arthritis	0.000805	0.00113	CcSEcCtD
Lurasidone—Rash—Prednisone—psoriatic arthritis	0.000798	0.00112	CcSEcCtD
Lurasidone—Dermatitis—Prednisone—psoriatic arthritis	0.000798	0.00112	CcSEcCtD
Lurasidone—Asthenia—Methotrexate—psoriatic arthritis	0.000759	0.00106	CcSEcCtD
Lurasidone—Nausea—Prednisone—psoriatic arthritis	0.000752	0.00105	CcSEcCtD
Lurasidone—Pruritus—Methotrexate—psoriatic arthritis	0.000749	0.00105	CcSEcCtD
Lurasidone—Diarrhoea—Methotrexate—psoriatic arthritis	0.000724	0.00101	CcSEcCtD
Lurasidone—Dizziness—Methotrexate—psoriatic arthritis	0.0007	0.000981	CcSEcCtD
Lurasidone—Vomiting—Methotrexate—psoriatic arthritis	0.000673	0.000943	CcSEcCtD
Lurasidone—Rash—Methotrexate—psoriatic arthritis	0.000667	0.000935	CcSEcCtD
Lurasidone—Dermatitis—Methotrexate—psoriatic arthritis	0.000667	0.000934	CcSEcCtD
Lurasidone—Nausea—Methotrexate—psoriatic arthritis	0.000629	0.000881	CcSEcCtD
